{"entity":{"type":"insider","cik":"0001715291","url":"/insider/0001715291","json_url":"/insider/0001715291.json","name":"Vazzano Joseph Walter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":18,"first":"2019-08-12","last":"2026-07-22","span_basis":"filed_date"},"name_variants":[{"name":"Vazzano Joseph Walter","source":"filing","n_filings":18,"first_seen":"2019-08-12","last_seen":"2026-07-22"}],"transactions":[{"id":6076075,"accession":"0001493152-26-034246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-034246","line_url":"/filing/0001493152-26-034246#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1478.0,"shares_display":"1,478","price_per_share":6.53,"price_display":"6.53","price_state":"stated","total_value":9651.34,"total_display":"9,651.34","total_whole":"9,651","shares_owned_after":492079.0,"shares_owned_after_display":"492,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-22","scope":"insider"},{"id":6212401,"accession":"0001493152-26-032746","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-032746","line_url":"/filing/0001493152-26-032746#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24880.0,"shares_display":"24,880","price_per_share":6.9637,"price_display":"6.96","price_state":"stated","total_value":173256.856,"total_display":"173,256.86","total_whole":"173,257","shares_owned_after":493557.0,"shares_owned_after_display":"493,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-09","scope":"insider"},{"id":5871455,"accession":"0001493152-26-028022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-26-028022","line_url":"/filing/0001493152-26-028022","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39067.0,"shares_display":"39,067","price_per_share":5.3619686538510765,"price_display":"5.36","price_state":"stated","total_value":209476.0294,"total_display":"209,476.03","total_whole":"209,476","shares_owned_after":518437.0,"shares_owned_after_display":"518,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-09","scope":"insider","n_lines":2},{"id":5871450,"accession":"0001493152-26-028022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-028022","line_url":"/filing/0001493152-26-028022#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10271.0,"shares_display":"10,271","price_per_share":5.4295,"price_display":"5.43","price_state":"stated","total_value":55766.3945,"total_display":"55,766.39","total_whole":"55,766","shares_owned_after":557504.0,"shares_owned_after_display":"557,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":6054286,"accession":"0001493152-26-010276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-010276","line_url":"/filing/0001493152-26-010276#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":785.0,"shares_display":"785","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":3736.6,"total_display":"3,736.60","total_whole":"3,737","shares_owned_after":567775.0,"shares_owned_after_display":"567,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-16","scope":"insider"},{"id":6093060,"accession":"0001493152-26-003284","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-003284","line_url":"/filing/0001493152-26-003284#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18666.0,"shares_display":"18,666","price_per_share":5.3309,"price_display":"5.33","price_state":"stated","total_value":99506.5794,"total_display":"99,506.58","total_whole":"99,507","shares_owned_after":568560.0,"shares_owned_after_display":"568,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-22","scope":"insider"},{"id":5168188,"accession":"0001493152-25-016542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-016542","line_url":"/filing/0001493152-25-016542#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9035.0,"shares_display":"9,035","price_per_share":5.3935,"price_display":"5.39","price_state":"stated","total_value":48730.2725,"total_display":"48,730.27","total_whole":"48,730","shares_owned_after":453631.0,"shares_owned_after_display":"453,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider"},{"id":4720229,"accession":"0001493152-25-012099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-012099","line_url":"/filing/0001493152-25-012099#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":7.3572,"price_display":"7.36","price_state":"stated","total_value":110358.0,"total_display":"110,358.00","total_whole":"110,358","shares_owned_after":462666.0,"shares_owned_after_display":"462,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-15","scope":"insider"},{"id":4149398,"accession":"0001641172-25-020575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-020575","line_url":"/filing/0001641172-25-020575#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":6.6409,"price_display":"6.64","price_state":"stated","total_value":9974.6318,"total_display":"9,974.63","total_whole":"9,975","shares_owned_after":477666.0,"shares_owned_after_display":"477,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-22","filed_date":"2025-07-22","scope":"insider"},{"id":4206662,"accession":"0001641172-25-018604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-018604","line_url":"/filing/0001641172-25-018604#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25411.0,"shares_display":"25,411","price_per_share":5.8557,"price_display":"5.86","price_state":"stated","total_value":148799.1927,"total_display":"148,799.19","total_whole":"148,799","shares_owned_after":479168.0,"shares_owned_after_display":"479,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-10","scope":"insider"},{"id":4276699,"accession":"0001641172-25-014178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-014178","line_url":"/filing/0001641172-25-014178#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17795.0,"shares_display":"17,795","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":120294.2,"total_display":"120,294.20","total_whole":"120,294","shares_owned_after":491246.0,"shares_owned_after_display":"491,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-06","filed_date":"2025-06-06","scope":"insider"},{"id":2787561,"accession":"0001493152-24-016062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-016062","line_url":"/filing/0001493152-24-016062#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5608.0,"shares_display":"5,608","price_per_share":3.14,"price_display":"3.14","price_state":"stated","total_value":17609.12,"total_display":"17,609.12","total_whole":"17,609","shares_owned_after":233868.0,"shares_owned_after_display":"233,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-25","filed_date":"2024-04-26","scope":"insider"},{"id":8734468,"accession":"0001493152-23-033142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-23-033142","line_url":"/filing/0001493152-23-033142","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.81944,"price_display":"3.82","price_state":"stated","total_value":11458.32,"total_display":"11,458.32","total_whole":"11,458","shares_owned_after":238179.0,"shares_owned_after_display":"238,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-20","scope":"insider","n_lines":2},{"id":6392131,"accession":"0001493152-22-033018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-033018","line_url":"/filing/0001493152-22-033018#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":95250.0,"shares_owned_after_display":"95,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":4987842,"accession":"0001104659-21-115916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-115916","line_url":"/filing/0001104659-21-115916#line-1","is_derivative":false,"issuer_cik":"0001644963","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001644963","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7160.0,"shares_display":"7,160","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":11599.2,"total_display":"11,599.20","total_whole":"11,599","shares_owned_after":65252.0,"shares_owned_after_display":"65,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-15","scope":"insider"},{"id":2862922,"accession":"0001104659-20-097594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-097594","line_url":"/filing/0001104659-20-097594#line-1","is_derivative":false,"issuer_cik":"0001644963","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001644963","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3840.0,"shares_display":"3,840","price_per_share":12.13,"price_display":"12.13","price_state":"stated","total_value":46579.2,"total_display":"46,579.20","total_whole":"46,579","shares_owned_after":57412.0,"shares_owned_after_display":"57,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-21","scope":"insider"},{"id":2297546,"accession":"0001104659-20-031410","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-031410","line_url":"/filing/0001104659-20-031410#line-3","is_derivative":false,"issuer_cik":"0001644963","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001644963","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1889.0,"shares_display":"1,889","price_per_share":7.94,"price_display":"7.94","price_state":"stated","total_value":14998.66,"total_display":"14,998.66","total_whole":"14,999","shares_owned_after":61252.0,"shares_owned_after_display":"61,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-10","scope":"insider"},{"id":2297542,"accession":"0001104659-20-031410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-031410","line_url":"/filing/0001104659-20-031410","is_derivative":false,"issuer_cik":"0001644963","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001644963","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":7.988666666666667,"price_display":"7.99","price_state":"stated","total_value":11983.0,"total_display":"11,983.00","total_whole":"11,983","shares_owned_after":59263.0,"shares_owned_after_display":"59,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-10","scope":"insider","n_lines":2},{"id":2339300,"accession":"0001104659-20-024815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-024815","line_url":"/filing/0001104659-20-024815#line-1","is_derivative":false,"issuer_cik":"0001644963","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001644963","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":9.09,"price_display":"9.09","price_state":"stated","total_value":10908.0,"total_display":"10,908.00","total_whole":"10,908","shares_owned_after":57863.0,"shares_owned_after_display":"57,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-25","scope":"insider"},{"id":8448106,"accession":"0001144204-19-039191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-039191","line_url":"/filing/0001144204-19-039191#line-2","is_derivative":false,"issuer_cik":"0001644963","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001644963","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2375.0,"shares_display":"2,375","price_per_share":5.56,"price_display":"5.56","price_state":"stated","total_value":13205.0,"total_display":"13,205.00","total_whole":"13,205","shares_owned_after":56663.0,"shares_owned_after_display":"56,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":8448102,"accession":"0001144204-19-039191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-039191","line_url":"/filing/0001144204-19-039191#line-1","is_derivative":false,"issuer_cik":"0001644963","issuer_name":"AVENUE THERAPEUTICS, INC.","issuer_ticker":"ATXI","issuer_name_source":null,"issuer_url":"/issuer/0001644963","owner_cik":"0001715291","owner_name":"Vazzano Joseph Walter","owner_display_name":"Vazzano Joseph Walter","owner_url":"/insider/0001715291","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2313.0,"shares_display":"2,313","price_per_share":5.62,"price_display":"5.62","price_state":"stated","total_value":12999.06,"total_display":"12,999.06","total_whole":"12,999","shares_owned_after":59038.0,"shares_owned_after_display":"59,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-08","filed_date":"2019-08-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ABEONA THERAPEUTICS INC.","url":"/issuer/0000318306","role":"Officer (Chief Financial Officer)","n_filings":13,"first_seen":"2022-11-21","last_seen":"2026-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001644963","name":"AVENUE THERAPEUTICS, INC.","url":"/issuer/0001644963","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2019-08-12","last_seen":"2021-09-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001715291","retrieved_at":"2026-08-25T06:41:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}